ask="0.7600"
ask_size="10000"
average_daily_volume="126352"
bid="0.5100"
bid_size="1000"
book_value="0.7250"
change="-0.0031"
change_from_200_day_moving_average="-0.6688"
change_from_50_day_moving_average="-0.5036"
change_from_52_week_high="-1.3021"
change_From_52_week_low="0.0479"
change_in_percent="-0.4422%"
close="0.6979"
dividend_pay_date="11/8/2012"
dividend_per_share="0.0000"
dividend_yield="0.0000"
earnings_per_share="-0.8100"
ebitda="-30.60M"
eps_estimate_current_year="-0.9300"
eps_estimate_next_quarter="-0.2300"
eps_estimate_next_year="-0.8600"
ex_dividend_date="11/9/2012"
float_shares="30530000"
high="0.7050"
high_52_weeks="2.0000"
last_trade_date="2/17/2017"
last_trade_price="0.6979"
last_trade_size="1102"
last_trade_time="4:00pm"
low="0.6876"
low_52_weeks="0.6500"
market_capitalization="26.97M"
moving_average_200_day="1.3667"
moving_average_50_day="1.2015"
name="Aviragen Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.1700"
open="0.7000"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-48.9350%"
percent_change_from_50_day_moving_average="-41.9128%"
percent_change_from_52_week_high="-65.1050%"
percent_change_from_52_week_low="+7.3692%"
previous_close="0.7010"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.9669"
price_per_sales="2.7646"
revenue="9.80M"
shares_outstanding="38649000"
short_ratio="1.3700"
stock_exchange="NMS"
symbol="AVIR"
volume="81288"
weeks_range_52="0.6500 - 2.0000"
